IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Albireo Pharma Inc CVR from 01345P106

Q1 2026 vs Q3 2026

Comparing institutional holders between quarters

Quarters

Q3 2026Q1 2026Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Ascentis Independent Advisors
UNCHANGED
Shares8 from 8
Change0 (0%)
Value$0 ($0)
Filed 2026-11-03
Status
Ascentis Independent Advisors
UNCHANGED8800%$0$0$02026-11-03
Showing 1 of 1 institutions